J9160 HCPCS Level II code: Injection, denileukin diftitox, 300 micrograms
CMS terminated J9160: its last date of service was Dec 31, 2023. It stays here for looking up older claims; newer services need a current code.
Official description
J9160Injection, denileukin diftitox, 300 micrograms
Short description: Denileukin diftitox inj
HCPCS · United States
Medicare details
The indicators CMS publishes with J9160 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2001
- Terminated after
- Dec 31, 2023
Where J9160 sits
- 1J codesDrugs administered other than orally
- 2Terminated J9160Injection, denileukin diftitox, 300 micrograms
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code J9160 still valid?
No. CMS terminated J9160; its last date of service was Dec 31, 2023. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover J9160?
CMS lists J9160’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9160
All J codesJ9144Injection, daratumumab, 10 mg and hyaluronidase-fihjJ9145Injection, daratumumab, 10 mgJ9150Injection, daunorubicin, 10 mgJ9151Injection, daunorubicin citrate, liposomal formulation, 10 mgJ9153Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabineJ9155Injection, degarelix, 1 mgJ9161Injection, denileukin diftitox-cxdl, 1 mcgJ9165Injection, diethylstilbestrol diphosphate, 250 mgJ9171Injection, docetaxel, 1 mgJ9172Injection, docetaxel (docivyx), 1 mgJ9173Injection, durvalumab, 10 mgJ9174Injection, docetaxel (beizray), 1 mg